Online inquiry

IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK12501MR)

This product GTTS-WK12501MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAMTS17 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_139057.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 170691
UniProt ID Q8TE56
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK12501MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK27449MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARL6IP5
GTTS-WK5702MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Synaptophysin
GTTS-WK12862MR IVTScrip™ mRNA-Human ADORA3, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADORA3
GTTS-WK8046MR IVTScrip™ mRNA-Human ADGRL2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADGRL2
GTTS-WK12380MR IVTScrip™ mRNA-Human ABLIM3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABLIM3
GTTS-WK12577MR IVTScrip™ mRNA-Human AES, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AES
GTTS-WK15969MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AKIRIN1
GTTS-WK21748MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW